DOP2017000144A - Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcina - Google Patents
Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcinaInfo
- Publication number
- DOP2017000144A DOP2017000144A DO2017000144A DO2017000144A DOP2017000144A DO P2017000144 A DOP2017000144 A DO P2017000144A DO 2017000144 A DO2017000144 A DO 2017000144A DO 2017000144 A DO2017000144 A DO 2017000144A DO P2017000144 A DOP2017000144 A DO P2017000144A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- trioxacarcine
- analogs
- preparation
- total synthesis
- methods
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
- 238000006257 total synthesis reaction Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094662P | 2014-12-19 | 2014-12-19 | |
| US201562186128P | 2015-06-29 | 2015-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2017000144A true DOP2017000144A (es) | 2017-09-29 |
Family
ID=56127867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2017000144A DOP2017000144A (es) | 2014-12-19 | 2017-06-19 | Síntesis total de trioxacarcina dc-45-a2 y preparación de análogos de trioxacarcina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10899773B2 (https=) |
| EP (1) | EP3233877A4 (https=) |
| JP (1) | JP2017537968A (https=) |
| KR (1) | KR20170122718A (https=) |
| CN (1) | CN107250144A (https=) |
| AU (1) | AU2015364347A1 (https=) |
| BR (1) | BR112017013194A2 (https=) |
| CA (1) | CA2970955A1 (https=) |
| CL (1) | CL2017001599A1 (https=) |
| CO (1) | CO2017007074A2 (https=) |
| CR (1) | CR20170331A (https=) |
| DO (1) | DOP2017000144A (https=) |
| EA (1) | EA201791388A1 (https=) |
| EC (1) | ECSP17046657A (https=) |
| GT (1) | GT201700139A (https=) |
| HK (1) | HK1243422A1 (https=) |
| IL (1) | IL252947A0 (https=) |
| MA (1) | MA41216A (https=) |
| MX (1) | MX2017008162A (https=) |
| PE (1) | PE20171787A1 (https=) |
| PH (1) | PH12017501147A1 (https=) |
| SG (1) | SG11201704935XA (https=) |
| WO (1) | WO2016100833A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210230178A1 (en) * | 2017-08-17 | 2021-07-29 | William Marsh Rice University | Trioxacarcin analogs and dimers as potent anticancer agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5815995A (ja) | 1981-07-22 | 1983-01-29 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法 |
| EP0157203A3 (en) * | 1984-04-04 | 1986-10-01 | American Cyanamid Company | Antitumor agents ll-d49194 alpha 1, ll-d49194 beta, ll-d49194 beta 2, ll-d49194 upsilon, ll-d49194 delta, ll-d49194 epsilon, ll-d49194 zeta, and ll-d49194 eta |
| JPS63135389A (ja) * | 1986-11-26 | 1988-06-07 | Kyowa Hakko Kogyo Co Ltd | Ｄｃ−４５類の誘導体 |
| US9102697B2 (en) | 2010-03-22 | 2015-08-11 | President And Fellows Of Harvard College | Trioxacarcins and uses thereof |
| US9775915B2 (en) * | 2012-11-26 | 2017-10-03 | President And Fellows Of Harvard College | Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof |
-
2015
- 2015-12-17 MA MA041216A patent/MA41216A/fr unknown
- 2015-12-18 US US15/537,319 patent/US10899773B2/en active Active
- 2015-12-18 BR BR112017013194-3A patent/BR112017013194A2/pt not_active Application Discontinuation
- 2015-12-18 WO PCT/US2015/066703 patent/WO2016100833A2/en not_active Ceased
- 2015-12-18 EP EP15871176.2A patent/EP3233877A4/en not_active Withdrawn
- 2015-12-18 CN CN201580076346.2A patent/CN107250144A/zh active Pending
- 2015-12-18 AU AU2015364347A patent/AU2015364347A1/en not_active Abandoned
- 2015-12-18 EA EA201791388A patent/EA201791388A1/ru unknown
- 2015-12-18 HK HK18102899.8A patent/HK1243422A1/zh unknown
- 2015-12-18 KR KR1020177020092A patent/KR20170122718A/ko not_active Withdrawn
- 2015-12-18 CR CR20170331A patent/CR20170331A/es unknown
- 2015-12-18 CA CA2970955A patent/CA2970955A1/en not_active Abandoned
- 2015-12-18 PE PE2017001101A patent/PE20171787A1/es unknown
- 2015-12-18 MX MX2017008162A patent/MX2017008162A/es unknown
- 2015-12-18 JP JP2017532666A patent/JP2017537968A/ja not_active Withdrawn
- 2015-12-18 SG SG11201704935XA patent/SG11201704935XA/en unknown
-
2017
- 2017-06-15 IL IL252947A patent/IL252947A0/en unknown
- 2017-06-19 GT GT201700139A patent/GT201700139A/es unknown
- 2017-06-19 PH PH12017501147A patent/PH12017501147A1/en unknown
- 2017-06-19 DO DO2017000144A patent/DOP2017000144A/es unknown
- 2017-06-19 CL CL2017001599A patent/CL2017001599A1/es unknown
- 2017-07-14 CO CONC2017/0007074A patent/CO2017007074A2/es unknown
- 2017-07-19 EC ECIEPI201746657A patent/ECSP17046657A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201704935XA (en) | 2017-07-28 |
| GT201700139A (es) | 2018-10-24 |
| HK1243422A1 (zh) | 2018-07-13 |
| EP3233877A4 (en) | 2018-10-17 |
| PH12017501147A1 (en) | 2018-03-05 |
| MA41216A (fr) | 2017-10-24 |
| KR20170122718A (ko) | 2017-11-06 |
| JP2017537968A (ja) | 2017-12-21 |
| US10899773B2 (en) | 2021-01-26 |
| WO2016100833A2 (en) | 2016-06-23 |
| US20190023717A1 (en) | 2019-01-24 |
| BR112017013194A2 (pt) | 2018-01-02 |
| MX2017008162A (es) | 2018-03-06 |
| CN107250144A (zh) | 2017-10-13 |
| CO2017007074A2 (es) | 2017-10-20 |
| IL252947A0 (en) | 2017-08-31 |
| WO2016100833A3 (en) | 2017-01-05 |
| CR20170331A (es) | 2017-11-17 |
| PE20171787A1 (es) | 2017-12-28 |
| EP3233877A2 (en) | 2017-10-25 |
| EA201791388A1 (ru) | 2017-11-30 |
| CL2017001599A1 (es) | 2018-11-09 |
| AU2015364347A1 (en) | 2017-07-13 |
| CA2970955A1 (en) | 2016-06-23 |
| ECSP17046657A (es) | 2019-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20170573A (es) | Lactamas bicíclicas y métodos de uso de las mismas | |
| BR112017012272A2 (pt) | derivados de 2-anilinopirimidina como moduladores de egfr | |
| EA201691272A1 (ru) | Тетрагидропиридопиразины в качестве модуляторов gpr6 | |
| MX373247B (es) | Nuevos derivados de octahidro-pirrolo[3,4-c]-pirrol y análogos del mismo como inhibidores de atotaxina. | |
| CO7400867A2 (es) | Modificador del sabor dulce | |
| MX2018003130A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas a receptor de interleucina-1 (irak) y usos de los mismos. | |
| UY36705A (es) | Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj | |
| NI201400079A (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| MX362259B (es) | Modificador del sabor dulce que tiene la formula estructural (i): 4-amino-2,2-dióxido-1h-benzo-(1,2,6)tiadiazin; composiciones que lo comprenden y un método para incrementar el sabor dulce. | |
| TW201613853A (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
| CR20170008A (es) | Compuestos de [1,2,4] triazol e imidazol sustituidos | |
| GT201700190A (es) | Desacetoxitubulisina h y análogos de esta | |
| MA38982A1 (fr) | Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| SV2017005381A (es) | Compuestos de imidazopiridazina | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CO2017003004A2 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
| MX2016012784A (es) | Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones. | |
| UY36070A (es) | Triterpenoides con actividad inhibidora de la maduración de hiv | |
| CO2017009989A2 (es) | Piridopirimidinonas y utilización de las mismas como moduladores de receptores de nmda | |
| DOP2016000211A (es) | Pirazinas moduladoras de gpr6 | |
| EA201591449A1 (ru) | Способы получения противораковых композиций | |
| CO2017007074A2 (es) | Sintesis total de trioxacarcina dc-45-a2 y preparación de analogos de trioxacarcina | |
| DOP2017000196A (es) | Derivados de tetrahidropiranil benzamida |